Figure 2.
Figure 2. Incidence of treatment-emergent AEs by treatment cycle. For (A) blinatumomab and (B) SOC.

Incidence of treatment-emergent AEs by treatment cycle. For (A) blinatumomab and (B) SOC.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal